Emzeltrectinib is a potent tyrosine kinase inhibitor with antineoplastic activity.
References:
[1]. Zhu Li, et al. Preparation of aminopyrazolopyrimidine compounds useful as neurotrophic factor tyrosine kinase receptor inhibitors: World Intellectual Property Organization, WO2018077246. 2018-05-03. [2]. WHO Drug Information-World Health Organization (WHO).
















